πŸ‡ΊπŸ‡Έ FDA
Patent

US 11707457

IRAK degraders and uses thereof

granted A61KA61K31/4545A61K31/4725

Quick answer

US patent 11707457 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kymera Therapeutics, Inc.
Grant date
Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4545, A61K31/4725, A61K31/497, A61K31/501